These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16269138)

  • 41. VPAC and PAC receptors: From ligands to function.
    Dickson L; Finlayson K
    Pharmacol Ther; 2009 Mar; 121(3):294-316. PubMed ID: 19109992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of different forms of vasoactive intestinal peptide on cAMP formation in the mammalian cerebral cortex.
    Dejda A; Gendek-Kubiak H; Nowak JZ
    Pol J Pharmacol; 2004; 56(4):421-5. PubMed ID: 15520496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
    Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
    J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
    Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
    Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paradoxical antagonism of PACAP receptor signaling by VIP in Xenopus oocytes via the type-C natriuretic peptide receptor.
    Lelièvre V; Hu Z; Ioffe Y; Byun JY; Flores A; Seksenyan A; Waschek JA
    Cell Signal; 2006 Nov; 18(11):2013-21. PubMed ID: 16723209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered synapsin I immunoreactivity and fear behavior in male and female rats subjected to long-term amygdala kindling.
    Fournier NM; Darnbrough AL; Wintink AJ; Kalynchuk LE
    Behav Brain Res; 2009 Jan; 196(1):106-15. PubMed ID: 18703092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
    El Zein N; Badran B; Sariban E
    J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease.
    Emson PC; Fahrenkrug J; Spokes EG
    Brain Res; 1979 Sep; 173(1):174-8. PubMed ID: 158404
    [No Abstract]   [Full Text] [Related]  

  • 49. Glutamate receptor subunits expression in memory-associated brain structures: regional variations and effects of aging.
    Liu P; Smith PF; Darlington CL
    Synapse; 2008 Nov; 62(11):834-41. PubMed ID: 18720514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
    Dejda A; Jozwiak-Bebenista M; Nowak JZ
    Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Long-term effects of recurrent seizures in neonate period on gamma-aminobutyric acid A receptor alpha1 and beta2 subunits expression in adult brain: experiment with rats].
    Bo T; Chen Y; Mao DA; Zhu XH; Li YF
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):275-8. PubMed ID: 17425879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
    Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production and purification of large quantities of the functional N-terminal ectodomain of human VPAC1 receptor.
    Couvineau A; Robert JC; Ramdani T; Lacapère JJ; Rouyer-Fessard C; Laburthe M
    J Mol Neurosci; 2008 Nov; 36(1-3):249-53. PubMed ID: 18592417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicity.
    Rangon CM; Dicou E; Goursaud S; Mounien L; Jégou S; Janet T; Muller JM; Lelièvre V; Gressens P
    Ann N Y Acad Sci; 2006 Jul; 1070():512-7. PubMed ID: 16888217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age related change in the vasoactive intestinal polypeptide-immunoreactive neurons in the cerebral cortex of aged rats.
    Cha CI; Lee EY; Lee YI; Baik SH
    Neurosci Lett; 1995 Sep; 197(1):45-8. PubMed ID: 8545052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
    J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of VIP and PACAP in islet function.
    Winzell MS; Ahrén B
    Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/inflammatory challenge.
    Favrais G; Couvineau A; Laburthe M; Gressens P; Lelievre V
    Peptides; 2007 Sep; 28(9):1727-37. PubMed ID: 17683829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.